Watch Demo

Global Drug Screening Industry

Global Drug Screening Industry

  • Publish Date:March 2023

  • Number of Pages:202

  • Report ID:5798424

  • Format:PDF

  • Publisher:Global Industry Analysts

$ 4950

Summary

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Drug Screening Market to Reach $28.2 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Drug Screening estimated at US$8.3 Billion in the year 2022, is projected to reach a revised size of US$28.2 Billion by 2030, growing at aCAGR of 16.6% over the period 2022-2030. Products, one of the segments analyzed in the report, is projected to record 14% CAGR and reach US$14.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Services segment is readjusted to a revised 20.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.5 Billion, While China is Forecast to Grow at 16% CAGR

The Drug Screening market in the U.S. is estimated at US$2.5 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.9 Billion by the year 2030 trailing a CAGR of 16% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.5% and 14.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.2% CAGR.

Select Competitors (Total 53 Featured)
- Alere, Inc.
- Alfa Scientific Designs, Inc.
- Dragerwerk AG & Co. KGaA
- F. Hoffmann-La Roche AG
- Laboratory Corporation of America Holdings (LabCorp)
- Lifeloc Technologies, Inc.
- Mpd, Inc.
- Omega Laboratories, Inc.
- OraSure Technologies, Inc.
- Premier Biotech, Inc.
- Psychemedics Corporation
- Quest Diagnostics, Inc.
- Shimadzu Corporation
- Siemens Healthineers
- Thermo Fisher Scientific, Inc.

Table of contents

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
Drug Screening - Global Key Competitors Percentage Market Share
in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for Drug
Screening by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 2: World Historic Review for Drug Screening by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 3: World 16-Year Perspective for Drug Screening by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Products by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 5: World Historic Review for Products by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 6: World 16-Year Perspective for Products by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Services by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 8: World Historic Review for Services by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 9: World 16-Year Perspective for Services by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Urine by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2022 through 2030 and
% CAGR

Table 11: World Historic Review for Urine by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 12: World 16-Year Perspective for Urine by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Breath by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 14: World Historic Review for Breath by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 15: World 16-Year Perspective for Breath by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for Oral
Fluid by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2022 through 2030 and
% CAGR

Table 17: World Historic Review for Oral Fluid by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 18: World 16-Year Perspective for Oral Fluid by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for Hair
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2022 through 2030 and
% CAGR

Table 20: World Historic Review for Hair by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 21: World 16-Year Perspective for Hair by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Other Sample Types by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 23: World Historic Review for Other Sample Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 24: World 16-Year Perspective for Other Sample Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 25: World Drug Screening Market Analysis of Annual Sales
in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
Drug Screening Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United States for 2023 (E)
Table 26: USA Recent Past, Current & Future Analysis for Drug
Screening by Component - Products and Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 27: USA Historic Review for Drug Screening by Component -
Products and Services Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 28: USA 16-Year Perspective for Drug Screening by
Component - Percentage Breakdown of Value Sales for Products
and Services for the Years 2014, 2023 & 2030

Table 29: USA Recent Past, Current & Future Analysis for Drug
Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and
Other Sample Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 30: USA Historic Review for Drug Screening by Sample Type -
Urine, Breath, Oral Fluid, Hair and Other Sample Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 31: USA 16-Year Perspective for Drug Screening by Sample
Type - Percentage Breakdown of Value Sales for Urine, Breath,
Oral Fluid, Hair and Other Sample Types for the Years 2014,
2023 & 2030

CANADA
Table 32: Canada Recent Past, Current & Future Analysis for
Drug Screening by Component - Products and Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 33: Canada Historic Review for Drug Screening by
Component - Products and Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 34: Canada 16-Year Perspective for Drug Screening by
Component - Percentage Breakdown of Value Sales for Products
and Services for the Years 2014, 2023 & 2030

Table 35: Canada Recent Past, Current & Future Analysis for
Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair
and Other Sample Types - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 36: Canada Historic Review for Drug Screening by Sample
Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 37: Canada 16-Year Perspective for Drug Screening by
Sample Type - Percentage Breakdown of Value Sales for Urine,
Breath, Oral Fluid, Hair and Other Sample Types for the Years
2014, 2023 & 2030

JAPAN
Drug Screening Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Japan for 2023 (E)
Table 38: Japan Recent Past, Current & Future Analysis for Drug
Screening by Component - Products and Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 39: Japan Historic Review for Drug Screening by Component -
Products and Services Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 40: Japan 16-Year Perspective for Drug Screening by
Component - Percentage Breakdown of Value Sales for Products
and Services for the Years 2014, 2023 & 2030

Table 41: Japan Recent Past, Current & Future Analysis for Drug
Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and
Other Sample Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 42: Japan Historic Review for Drug Screening by Sample
Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 43: Japan 16-Year Perspective for Drug Screening by
Sample Type - Percentage Breakdown of Value Sales for Urine,
Breath, Oral Fluid, Hair and Other Sample Types for the Years
2014, 2023 & 2030

CHINA
Drug Screening Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in China for 2023 (E)
Table 44: China Recent Past, Current & Future Analysis for Drug
Screening by Component - Products and Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 45: China Historic Review for Drug Screening by Component -
Products and Services Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 46: China 16-Year Perspective for Drug Screening by
Component - Percentage Breakdown of Value Sales for Products
and Services for the Years 2014, 2023 & 2030

Table 47: China Recent Past, Current & Future Analysis for Drug
Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and
Other Sample Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 48: China Historic Review for Drug Screening by Sample
Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 49: China 16-Year Perspective for Drug Screening by
Sample Type - Percentage Breakdown of Value Sales for Urine,
Breath, Oral Fluid, Hair and Other Sample Types for the Years
2014, 2023 & 2030

EUROPE
Drug Screening Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Europe for 2023 (E)
Table 50: Europe Recent Past, Current & Future Analysis for
Drug Screening by Geographic Region - France, Germany, Italy,
UK and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 51: Europe Historic Review for Drug Screening by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 52: Europe 16-Year Perspective for Drug Screening by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2014, 2023 & 2030

Table 53: Europe Recent Past, Current & Future Analysis for
Drug Screening by Component - Products and Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 54: Europe Historic Review for Drug Screening by
Component - Products and Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 55: Europe 16-Year Perspective for Drug Screening by
Component - Percentage Breakdown of Value Sales for Products
and Services for the Years 2014, 2023 & 2030

Table 56: Europe Recent Past, Current & Future Analysis for
Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair
and Other Sample Types - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 57: Europe Historic Review for Drug Screening by Sample
Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 58: Europe 16-Year Perspective for Drug Screening by
Sample Type - Percentage Breakdown of Value Sales for Urine,
Breath, Oral Fluid, Hair and Other Sample Types for the Years
2014, 2023 & 2030

FRANCE
Drug Screening Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in France for 2023 (E)
Table 59: France Recent Past, Current & Future Analysis for
Drug Screening by Component - Products and Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 60: France Historic Review for Drug Screening by
Component - Products and Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 61: France 16-Year Perspective for Drug Screening by
Component - Percentage Breakdown of Value Sales for Products
and Services for the Years 2014, 2023 & 2030

Table 62: France Recent Past, Current & Future Analysis for
Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair
and Other Sample Types - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 63: France Historic Review for Drug Screening by Sample
Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 64: France 16-Year Perspective for Drug Screening by
Sample Type - Percentage Breakdown of Value Sales for Urine,
Breath, Oral Fluid, Hair and Other Sample Types for the Years
2014, 2023 & 2030

GERMANY
Drug Screening Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Germany for 2023 (E)
Table 65: Germany Recent Past, Current & Future Analysis for
Drug Screening by Component - Products and Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 66: Germany Historic Review for Drug Screening by
Component - Products and Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 67: Germany 16-Year Perspective for Drug Screening by
Component - Percentage Breakdown of Value Sales for Products
and Services for the Years 2014, 2023 & 2030

Table 68: Germany Recent Past, Current & Future Analysis for
Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair
and Other Sample Types - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 69: Germany Historic Review for Drug Screening by Sample
Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 70: Germany 16-Year Perspective for Drug Screening by
Sample Type - Percentage Breakdown of Value Sales for Urine,
Breath, Oral Fluid, Hair and Other Sample Types for the Years
2014, 2023 & 2030

ITALY
Table 71: Italy Recent Past, Current & Future Analysis for Drug
Screening by Component - Products and Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 72: Italy Historic Review for Drug Screening by Component -
Products and Services Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 73: Italy 16-Year Perspective for Drug Screening by
Component - Percentage Breakdown of Value Sales for Products
and Services for the Years 2014, 2023 & 2030

Table 74: Italy Recent Past, Current & Future Analysis for Drug
Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and
Other Sample Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 75: Italy Historic Review for Drug Screening by Sample
Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 76: Italy 16-Year Perspective for Drug Screening by
Sample Type - Percentage Breakdown of Value Sales for Urine,
Breath, Oral Fluid, Hair and Other Sample Types for the Years
2014, 2023 & 2030

UNITED KINGDOM
Drug Screening Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United Kingdom for 2023 (E)
Table 77: UK Recent Past, Current & Future Analysis for Drug
Screening by Component - Products and Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 78: UK Historic Review for Drug Screening by Component -
Products and Services Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 79: UK 16-Year Perspective for Drug Screening by
Component - Percentage Breakdown of Value Sales for Products
and Services for the Years 2014, 2023 & 2030

Table 80: UK Recent Past, Current & Future Analysis for Drug
Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and
Other Sample Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 81: UK Historic Review for Drug Screening by Sample Type -
Urine, Breath, Oral Fluid, Hair and Other Sample Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 82: UK 16-Year Perspective for Drug Screening by Sample
Type - Percentage Breakdown of Value Sales for Urine, Breath,
Oral Fluid, Hair and Other Sample Types for the Years 2014,
2023 & 2030

REST OF EUROPE
Table 83: Rest of Europe Recent Past, Current & Future Analysis
for Drug Screening by Component - Products and Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 84: Rest of Europe Historic Review for Drug Screening by
Component - Products and Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 85: Rest of Europe 16-Year Perspective for Drug Screening
by Component - Percentage Breakdown of Value Sales for Products
and Services for the Years 2014, 2023 & 2030

Table 86: Rest of Europe Recent Past, Current & Future Analysis
for Drug Screening by Sample Type - Urine, Breath, Oral Fluid,
Hair and Other Sample Types - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 87: Rest of Europe Historic Review for Drug Screening by
Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample
Types Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 88: Rest of Europe 16-Year Perspective for Drug Screening
by Sample Type - Percentage Breakdown of Value Sales for Urine,
Breath, Oral Fluid, Hair and Other Sample Types for the Years
2014, 2023 & 2030

ASIA-PACIFIC
Drug Screening Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Asia-Pacific for 2023 (E)
Table 89: Asia-Pacific Recent Past, Current & Future Analysis
for Drug Screening by Component - Products and Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 90: Asia-Pacific Historic Review for Drug Screening by
Component - Products and Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 91: Asia-Pacific 16-Year Perspective for Drug Screening
by Component - Percentage Breakdown of Value Sales for Products
and Services for the Years 2014, 2023 & 2030

Table 92: Asia-Pacific Recent Past, Current & Future Analysis
for Drug Screening by Sample Type - Urine, Breath, Oral Fluid,
Hair and Other Sample Types - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 93: Asia-Pacific Historic Review for Drug Screening by
Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample
Types Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 94: Asia-Pacific 16-Year Perspective for Drug Screening
by Sample Type - Percentage Breakdown of Value Sales for Urine,
Breath, Oral Fluid, Hair and Other Sample Types for the Years
2014, 2023 & 2030

REST OF WORLD
Table 95: Rest of World Recent Past, Current & Future Analysis
for Drug Screening by Component - Products and Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 96: Rest of World Historic Review for Drug Screening by
Component - Products and Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 97: Rest of World 16-Year Perspective for Drug Screening
by Component - Percentage Breakdown of Value Sales for Products
and Services for the Years 2014, 2023 & 2030

Table 98: Rest of World Recent Past, Current & Future Analysis
for Drug Screening by Sample Type - Urine, Breath, Oral Fluid,
Hair and Other Sample Types - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 99: Rest of World Historic Review for Drug Screening by
Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample
Types Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 100: Rest of World 16-Year Perspective for Drug Screening
by Sample Type - Percentage Breakdown of Value Sales for Urine,
Breath, Oral Fluid, Hair and Other Sample Types for the Years
2014, 2023 & 2030

IV. COMPETITION

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.